Research & Development: Page 77

PharmaVoice Team/PharmaVoice

The True Value of Educational Outcomes Measurement

VIEW on Medical Education August 2007 The True Value of Educational Outcomes Measurement Sherri Foster, Senior VP and General Manager Outcomes measurement has become the buzzword in continuing medical education (CME) over the past few years. It comes amid growing recognition among stak...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

A Process Map for Maximizing the Impact of Promotional Medical Education

A Process Map for Maximizing the Impact of Promotional Medical Education Neil Matheson CEO Axis Healthcare Communications LLC CME Planning The goal of all medical education programs is to improve patient care. This goal can be achieved if the participants in the program recognize and...
By PharmaVoice Team • Jan. 2, 2008
Explore the Trendline➔

Stock via Getty Images

Trendline

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

Emerging Psychographic Segmentation Strategies for Developing Customized Professional Education

Emerging Psychographic Segmentation Strategies for Developing Customized Professional Education David St. Peter, M.D. President VIEW on Medical Education August 2007 Why Customization Is Important Physicians are people too, and just like everyone else, they have innate differences th...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

Letter from the Editor The Forum Medical Education: The State of CME — Continuing medical education could be argued to be one of the most ever-changing fundamentals in the healthcare industry today. Ensuring that CME remains in compliance with the latest guidelines and technologies is an ongoing ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

Old School, New School Taren Grom We look forward to discussing the latest industry trends at the Annual Conference on CME Provider/Industry Collaboration, Oct. 17-19. Please stop by to say hello. Letter from the Editor VIEW on Medical Education August 2007 In September 2006, ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Making Partnerships Work for Your Educational Programs

Making Partnerships Work for Your Educational Programs VIEW on Medical Education August 2007 Susan Grady, Chief Medical Director Haleh Kadkhoda, VP of Educational Programs Making the decision to collaborate on an educational initiative is not an easy one. Broach the subject with your team...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

No Crystal Ball Required: The Future of CME Is Already Here

No Crystal Ball Required: The Future of CME Is Already Here August 2007 VIEW on Medical Education E-CME Niki Oquist, M.D., FAAP, Senior VP, Medical Affairs Advances in technology are changing the way groups and individuals communicate with and amongst one another, and CME providers must embr...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Cover

PharmaVOICE 100 of the Most Inspiring People July/August 2007 Download PDF
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Postmarketing Safety in the Spotlight

Improving prescription drug safety and oversight have taken center stage both within Congress and with regulatory authorities. Postmarketing research is an important element of commercialization that enables companies to expand existing markets, enter new markets, develop and deliver messaging th...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Success Beyond the Silos

By Robin Robinson Forum Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. More and more pharmaceutical companies are breaking out of their siloed structure to re...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Marketplace

Featured Product and Service Showcases AmerisourceBergen Specialty Group Axis Healthcare Communications LLC Cadent Medical Communications The Center for Biomedical Continuing Education CME LLC cme2 The Curry Rockefeller Group LLC Excerpta Medica Innovia Education Institute LLC Institu...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The State of CME

August 2007 VIEW on Medical Education The State of CME by Kate Guerriero Continuing medical education could be argued to be one of the most ever-changing fundamentals in the healthcare industry today. Ensuring that CME remains in compliance ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

With so much negative press these days surrounding the pharmaceutical and life-sciences industries, it is our pleasure to once again be able to relate the positive aspects of our industry. We want to thank the thousands of individuals who took the time to send in their thoughtful write ups as par...
By Taren Grom • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Patient Advocates

With an unwavering commitment to patients and protecting their rights, these forward-thinking individuals are advocating best practices for clinical-trial recruitment and education. Zane Wilson Speaking up for Those in Need Despite an often uphill battle to provide better facilities for patients ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Researchers & Scientists

Matthew Coffey, Ph.D. Barry Eisenstein, M.D. Robert Lanza, M.D. Christine Smith Ana Szarfman, M.D., Ph.D. From discovery through clinical development, the researchers and scientists behind the medicines are making a significant impact on the pipelines of today and of the future. Current positions...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Technologists

These innovators of technology-based solutions are improving connections across silos to facilitate the drug-development process and customer interactions. PharmaVOICE 100 July/August 2007 Vikas Vats The Sky’s the limit for innovation Current position VP, marketRx Place and date of Birth New Delh...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Inverting the Enrollment Trend of Clinical Trials

Inverting the Enrollment Trend of Clinical Trials One of the largest challenges facing the industry today is inverting the trend of clinical trials failing to complete enrollment on time. Raising awareness of a particular clinical trial with call-to-action advertising, such as broadcast televi...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Guidance and Technology: A Single-Source Solution

Guidance and Technology: A Single-Source Solution Rick Piazza, VP, Product Strategy In today’s technology-reliant clinical-trial studies, it is crucial that software providers maintain a staff of in-house experts to offer counsel and guidance to sponsors. These experts act as process partne...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

New Techniques Drive Patient Enrollment for Trials

New Techniques Drive Patient Enrollment for Trials The number of clinical trials for new drugs continues to grow, increasing the competition for patients. IMS data show that new drug-discovery technologies are fueling record worldwide growth. There are more than 13,000 studies projected for 20...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Clinical Services: Managing the Moving Parts

Clinical Services: Managing the Moving Parts By Taren Grom, Editor The Cost of Doing Business The cost of drug development remains on the rise, with most estimates showing that the clinical-trials stage alone accounts for 40% of all costs related to R&D. Our Forum experts discuss...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

Letter from the Editor The Forum Clinical Services: Managing the Moving Parts — The clinical-research process is complex and requires integrated, sophisticated processes, technologies, and management to reduce costs, improve timelines, and produce safe therapeutics. Company Listing by Topic of In...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials

Integration and Workflow Issues for Clinical-Services Providers to Ensure Smooth Trials Mary T. Stefanzick, Associate Director of Operations An ongoing imperative in clinical research for pharma and biotech companies is to accelerate processes and timelines to get new products to market ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Overcoming Poor Quality Data for ECG Collection

Overcoming Poor Quality Data for ECG Collection Timothy Callahan, Ph.D., Chief Scientific Officer The ICH E14 has become the touchstone guideline when designing and implementing Thorough QT (TQT) trials. Even protocols that are not designed primarily as a QT trial often use recommendations fr...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Using Advanced Simulation in Clinical Operations

Using Advanced Simulation in Clinical Operations Jack Porter, President and CEO, ePharmamindshare The introduction of supercomputers and sophisticated simulation software for planning and optimizing clinical trials is rapidly becoming established in the pharmaceutical industry. These simulati...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Benefits of Using an EDC System to Collect and Reconcile Serious Adverse Events

Benefits of Using an EDC System to Collect and Reconcile Serious Adverse Events Gary Tyson, Senior VP, Clinical Development Practice Marybeth Lynch, Associate Practice Executive, Clinical Development Practice Collecting and reconciling adverse events (AEs) and serious adverse events (SAEs)...
By PharmaVoice Team • Jan. 2, 2008